Watchlist Price Alert

LakeShore Biopharma Co. L... (LSB)

NASDAQ: LSB · Real-Time Price · USD

1.19

-0.06 (-4.80%)

At close: May 02, 2025, 3:57 PM

1.18

-0.84%

After-hours: May 02, 2025, 04:57 PM EDT

LakeShore Biopharma Ltd Balance Sheet Statement

Financials in CNY. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	246.35M	222.66M	259.91M	94.75M	370.11M	500.59K	4.13M	4.58M	5.64M	6.94M	12.03M	n/a	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	1.44B	1.34B	1.27B	1.27B	1.29B	1.29B	n/a	n/a
Other Long-Term Assets	57.99M	104.96M	28.03M	27.07M	20.92M	n/a	n/a	n/a	n/a	n/a	n/a	1.59M	596.26K
Receivables	444.16M	403.12M	429.37M	495.91M	463.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	205.09M	190.78M	212.82M	182.37M	185.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.57M	77.23K	11.34M	223.21M	10.67M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	903.17M	826.77M	934.61M	1.01B	1.04B	2.06M	4.23M	4.98M	6.54M	8.37M	14.05M	n/a	n/a
Property-Plant & Equipment	480.62M	568.83M	571.29M	577.81M	582.89M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	71.25M	n/a	74.64M	76.33M	78.06M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	609.86M	683.96M	676.68M	683.7M	683.77M	1.44B	1.34B	1.27B	1.27B	1.29B	1.29B	1.59M	596.26K
Total Assets	1.51B	1.51B	1.61B	1.69B	1.72B	1.44B	1.35B	1.28B	1.28B	1.3B	1.31B	1.59M	596.26K
Account Payables	67.77M	10.92M	11.64M	10.18M	80.44M	267.05M	n/a	195.72M	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	391.51M	2.3M	2.3M	2.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	318.54M	423.88M	25.03M	23.65M	193.74M	1.17B	n/a	709.76M	n/a	n/a	n/a	262.62K	32.69K
Other Current Liabilities	163.16M	-1.1M	1.18B	1.11B	108.8M	-3.43B	2.62M	600.47M	-170M	711.61K	5.06M	1.19M	424.15K
Total Current Liabilities	802.23M	883.02M	663.12M	651.74M	658.76M	4.5M	2.62M	845.55K	907.97K	711.61K	5.06M	1.45M	456.85K
Long-Term Debt	98.98M	125.09M	361.97M	343.29M	293.79M	2.03B	n/a	1.61B	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	24.83M	5.81M	2.19M	2.38M	8.79M	-2.21B	26.86M	8.7B	284.47M	107.16M	115.36M	n/a	n/a
Total Long-Term Liabilities	125.6M	131.47M	391.07M	377.39M	332.54M	40.17M	73.76M	81.75M	128.65M	152.33M	160.62M	n/a	n/a
Total Liabilities	927.82M	1.04B	1.05B	1.03B	991.3M	44.67M	76.38M	82.59M	129.56M	153.04M	165.69M	1.45M	456.85K
Total Debt	424.46M	558.2M	554.2M	526.61M	498.63M	n/a	n/a	n/a	n/a	n/a	n/a	262.62K	32.69K
Common Stock	26.11K	12K	12.3K	12K	12.3K	1.44B	1.34B	3.65K	3.66K	3.71K	6.05K	4.27K	3.75K
Retained Earnings	-2.31B	-2.13B	-2.05B	-1.94B	-1.87B	-42.61M	-72.16M	-77.44M	-122.98M	-144.66M	-30.29M	-23.87K	-23.73K
Comprehensive Income	-58.18M	-56.07M	-51.25M	-52.57M	-54.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	585.21M	474.6M	557.1M	660.75M	728.45M	1.39B	1.27B	1.19B	1.15B	1.15B	1.14B	140.23K	139.41K
Total Investments	n/a	n/a	n/a	n/a	n/a	1.44B	1.34B	1.27B	1.27B	1.29B	1.29B	n/a	n/a